CD8A and lung carcinoma: KEAP1 loss occurs in a substantial proportion of lung cancer patients (19% LUADs and 12% LUSCs) and is associated with an immunosuppressive TME characterized by low infiltration of CD8+ TILs and NK cells [66,67].